Skip to main content
$0.220 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
2 November 2026 at 7:25pm
If you were already registered, log in here.

Short Interest

ASIC data, 27 Oct 2026

% Shorted

7.75% 0.10
vs 7.85% prior report

Most Shorted Rank

38th
of 720 shorted ASX stocks

Peak Short

10.17%
Oct 2026

Days to Cover

7.8
at 50d avg vol
Subject
AYA Ann: Notification regarding unquoted securities - AYA

AYA Ann: Notification regarding unquoted securities - AYA

AYA Ann: Notification regarding unquoted securities - AYA

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Change of Director's Interest Notice - John Barrington

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Artrya Appoints Accomplished American Physician as CMO

AYA Ann: Conference Call - Update on US FDA Application

AYA Ann: Update on US FDA Application for Artrya Salix

AYA Ann: Change of Director's Interest Notice - John Barrington

AYA Ann: Artrya Signs First U.S. Hospital Clinical Partnership

AYA Ann: Application for quotation of securities - AYA

AYA Ann: Quarterly Activity Report and Appendix 4C for Q3 FY22

AYA Ann: Change of Registered Office

AYA Ann: Application for quotation of securities - AYA

AYA Ann: Quarterly Conference Call Details

AYA Ann: Release of Shares from Escrow

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Notification regarding unquoted securities - AYA

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Artrya Opens US Operations in Los Angeles

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Artrya Half Year Financial Report Presentation

AYA Ann: Appendix 4D and Half Year Financial Report

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Half Year Financial Report & Shareholder Conference Call

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Quarterly Results Conference Call

AYA Ann: Quarterly Activity Report and Appendix 4C for Q2 FY22

AYA Ann: Notification regarding unquoted securities - AYA

AYA Ann: Artrya appoints Dr Jacque Sokolov as United States Advisor

AYA Ann: Artrya Update December 2021

AYA Ann: Notice of Initital Substantial Holder - Artrya Limited

AYA Ann: Notice of Initial Substantial Holder - John Konstantopoulos

AYA Ann: Notice of Initial Substantial Holder - John Barrington

AYA Ann: Initial Director's Interest Notice - Bernie Ridgeway

AYA Ann: Initial Director's Interest Notice - John Konstantopoulos

AYA Ann: Initial Director's Interest Notice - John Barrington AM

AYA Ann: Cardiac imaging software company Artrya Lists on ASX

AYA Ann: Pre-Quotation Disclosure

AYA Ann: Top 20 Holders

AYA Ann: Distribution Schedule

AYA Ann: Securities Trading Policy

AYA Ann: Corporate Governance Statement

AYA Ann: Incentive Awards Plan 2021

AYA Ann: Employee Option Plan 2019

AYA Ann: Financial Report for period ended 30 June 2021

AYA Ann: Financial Report for period ended 30 June 2020

If you were already registered, log in here.
S88
CX8
MAV $7.5m raise
MTX $12m raise
RDO $30m raise
MBM